Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis

IMPORTANCE: Debate continues about the value of event adjudication in clinical trials and whether independent centralized assessments improve reliability and validity of study results in masked randomized trials compared with local, investigator-assessed end points. OBJECTIVE: To assess the results...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrant, Mary, Easton, J. Donald, Adelman, Eric E., Cucchiara, Brett L., Barsan, William G., Tillman, Holly J., Elm, Jordan J., Kim, Anthony S., Lindblad, Anne S., Palesch, Yuko Y., Zhao, Wenle, Pauls, Keith, Walsh, Kyle B., Martí-Fàbregas, Joan, Bernstein, Richard A., Johnston, S. Claiborne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735409/
https://www.ncbi.nlm.nih.gov/pubmed/31490536
http://dx.doi.org/10.1001/jamanetworkopen.2019.10769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735409/
https://www.ncbi.nlm.nih.gov/pubmed/31490536
http://dx.doi.org/10.1001/jamanetworkopen.2019.10769

Ejemplares similares